Lakshmi Menon, 63, talks about how she was diagnosed with Rheumatoid Arthritis (RA) and her continuous struggle to manage its pain and debilitating symptoms. This is the first of a two-part series.
I first got to know of Rheumatoid Arthritis (RA) when my twin sister was afflicted with this debilitating disease when she was in her early 30s. She had a very virulent form of RA which caused her severe pain and, in no time caused deformation of her hands and feet and reduced mobility. It was her…

Tofacitinib (Xeljanz®) is the first of a unique class of oral kinase inhibitors to be FDA approved for the treatment of rheumatoid arthritis (RA). Tofacitinib is a selective inhibitor of Janus kinase (JAK) enzymes. these enzymes mediate signaling for several important cytokines that cause the inflammation in Rheumatoid Arthritic patients.
Changed
06/Sep/2014
Condition